tm logo

Monitor this mark

View On USPTO

ALPROLIX
Live/Registered
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED

accepted and acknowledged

on 08 Oct 2020

Last Applicant/ Owned by

BIOVERATIV THERAPEUTICS INC.

225 SECOND AVENUE

WALTHAM

MA

02451

Serial Number

85411805 filed on 31st Aug 2011

Registration Number

4593229 registered on 26th Aug 2014

in the Principal Register

Correspondent Address

Karen Lim

Karen Lim Fross Zelnick Lehrman & Zissu, P.C.

New York, NY 10036

United States

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

ALPROLIX

Pharmaceutical preparations for the treatment of hemophilia

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations for the treatment of hemophilia

First Use Date in General

05th May 2014

First Use Date in Commerce

05th May 2014

Mark Details

Serial Number

No 85411805

Mark Type

No Service/Collective Mark

Attorney Docket Number

No BIOV 2008069

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
26th Sep 2024TEAS SECTION 8 & 9 RECEIVED
26th Aug 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
08th Oct 2020REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
08th Oct 2020NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
06th Oct 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
18th Aug 2020TEAS SECTION 8 & 15 RECEIVED
10th Oct 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10th Oct 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
26th Aug 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
22nd Feb 2017AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP